Overview Pembrolizumab (Keytruda): CADTH Reimbursement Advice: Indicator: Together with chemotherapy, for the remedy of adult sufferers with regionally recurrent unresectable or metastatic triple-detrimental breast most cancers who have not received prior chemotherapy for metastatic illness and whose tumours express programmed cell death-ligand one (put together positive rating ≥ ten) as https://sandrab457sst9.birderswiki.com/user